The LancetVolume 395, Issue 10234, 2–8 May 2020, Pages 1407-1409CommentTrials of anti-tumour necrosis factor therapy for COVID-19 are urgently neededAuthor links open overlay panelMarc Feldmann a, Ravinder N Maini b, James N Woody c, Stephen T Holgate d, Gregory Winter e, Matthew Rowland f, Duncan Richards g, Tracy Hussell hShow moreShareCitehttps://doi.org/10.1016/S0140-6736(20)30858-8Get rights and contentPrevious article in issueNext article in issueRecommended articlesCited by (0)View Abstract© 2020 Elsevier Ltd. All rights reserved.